Trial intelligence / Profile preview

Privigen vs Intragam P in Primary Immune Deficiency

NCT00405184Phase 3Completed

Sponsor
CSL Limited
Start
May 2007
Primary completion
Jul 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of intravenous immunoglobulin G in primary immunodeficiency (PI), sponsored by CSL Limited. Started May 2007; status: completed.

02

Drugs

intravenous immunoglobulin G
03

Conditions

primary immunodeficiency (PI)

Beyond the preview

Go deeper on NCT00405184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00405184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call